Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 5, 2023Blood Cancer JournalOpen Access

Characteristic immunophenotype and gene co-mutational status orchestrate to optimize the prognosis of CEBPA mutant acute myeloid leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

XCXinjie ChenJiangnan UniversityDADiyaer AbuduainiYZYuliang ZhangNanchang University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chen et al. (2023) studied this question.

synapsesocial.com/papers/6aae2ca05a2795d39ca385d9https://doi.org/10.1038/s41408-023-00838-2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions2022 · 45 citations
  2. 2<i>CEBPA</i> mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome2021 · 173 citations
  3. 3Prognostic impact of <i>CEBPA</i> bZIP domain mutation in acute myeloid leukemia2021 · 122 citations
  4. 4Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN2022 · 3,298 citations
  5. 5The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA2013 · 155 citations